Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased C5a receptor expression in sepsis.

Niels C Riedemann1, Ren-Feng Guo, Thomas A Neff

  • 1Department of Pathology, University of Michigan Medical School, 1301 Catherine Road, Ann Arbor, MI 48109, USA.

The Journal of Clinical Investigation
|July 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of the "critical view/open book" concept for implementing standardized right hemicolectomy with complete mesocolic excision-results from a series of minimally invasive surgical training courses.

Surgical endoscopy·2026
Same author

New Analogs of the Compstatin Family of Clinical Complement Inhibitors with Low Picomolar Target Affinity.

Journal of medicinal chemistry·2026
Same author

Extracellular Histones Associate with Blood-Brain Barrier Disruption and Astrocyte-Mediated Neuroinflammation During Polymicrobial Sepsis.

International journal of molecular sciences·2026
Same author

[The Dynamics of the German Healthcare System Require Rapid Team Development - Colorectal Fast Track Implementation as a Prototype with a Steep Learning Curve].

Zentralblatt fur Chirurgie·2025
Same author

Clinical C3 Inhibition With AMY-101 Reveals Novel Insights Into IL-8-Driven Inflammation in COVID-19.

Immunology·2025
Same author

'Complement-ing' tissue inflammation via granzyme K?

Nature immunology·2025

Blocking the C5a receptor (C5aR) significantly improves survival during sepsis. This study shows C5aR is upregulated in major organs and blocking it reduces inflammation and bacterial load in a rodent sepsis model.

Area of Science:

  • Immunology
  • Pathophysiology
  • Sepsis Research

Background:

  • Excessive complement activation product C5a is detrimental in sepsis.
  • The role and distribution of the C5a receptor (C5aR) in sepsis remain unclear.

Purpose of the Study:

  • To investigate the expression of C5aR in various organs during sepsis.
  • To evaluate the therapeutic potential of blocking C5aR in a rodent model of sepsis.

Main Methods:

  • Cecal ligation and puncture (CLP) model in mice.
  • Immunoreactivity and mRNA expression analysis of C5aR in lung, liver, kidney, and heart.
  • Administration of C5aR blocking antibody (alphaC5aR) or C5a blocking antibody (alphaC5a).
  • Assessment of survival rates, serum cytokine levels (IL-6, TNF-alpha), and bacterial counts.

Related Experiment Videos

Main Results:

  • C5aR immunoreactivity and mRNA expression were significantly increased in the lung, liver, kidney, and heart early in sepsis.
  • Treatment with alphaC5aR or alphaC5a dramatically improved survival rates compared to controls.
  • alphaC5aR treatment led to reduced serum IL-6 and TNF-alpha levels and lower bacterial counts in organs.

Conclusions:

  • C5aR is upregulated in multiple organs during the early stages of sepsis.
  • Blockade of C5aR confers significant protection against lethal sepsis.
  • Targeting C5aR represents a promising therapeutic strategy for sepsis treatment.